The following table shows the activity within the liability account for the nine months ended September 30, 2024: | | | | | | | | | | (in thousands) | | September 30, 2024 | Liability related to sale of future Jemperli royalties and milestones – balance at 12/31/2023 | | $ | 278,090 | | | Proceeds from sale of future royalties | | 50,000 | | | Issuance costs related to the sale of future royalties | | (103) | | | Amortization of issuance costs | | 41 | | | Royalty and milestone payments to Sagard | | (39,875) | | | Non-cash interest expense recognized | | 31,978 | | Liability related to sale of future royalties and milestones – ending balance | | $ | 320,131 | |
The following table shows the activity within the liability account for the nine months ended September 30, 2024: | | | | | | | | | | (in thousands) | | September 30, 2024 | Liability related to sale of future Zejula royalties and milestones – balance at 12/31/2023 | | $ | 32,717 | | | | | | | | | Amortization of issuance costs | | 22 | | | Royalty and milestone payments to DRI | | (2,948) | | | Non-cash interest expense recognized | | 642 | | Liability related to sale of future royalties and milestones – ending balance | | $ | 30,433 | |
|